arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Nakamoto Inc.

NAKA Health Care Medical/Nursing Services
$8.15
▲ +0.2% Today
as of Sep 4, 16:52 ET
Last 30 days +73.35% Jul 27 → Sep 04
$3.96 $5.13 $6.30 $7.46 $8.63 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$8.08
High
$8.41
Low
$7.53
Volume
$212,687
Avg Vol
$322,436
Mkt Cap
$88M
P/E (TTM)
—
Beta
—
52w High
$343.20
52w Low
$3.33
Div Yield
—
Shares Out
$18M

Recent Press Releases & News last 60 days · 2 items

Aug 31 · 15:53 Stocktwits
Nakamoto CEO David Bailey Says Bitcoin’s Corporate Turn Isn’t A ‘Betrayal’ – Eyes Bigger Push Into M&A
Jul 15 · 16:45 TheStreet
Why is Nakamoto (NAKA) stock surging on July 15?

Overview

52-week range
$3.33
$343
1% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+9.5%
50% positive
Latest IV / EM
118%
EM ±18.5% · $8 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-6.65$-5.00$-3.35$-1.69$-0.04 Actual $-0.04Actual $-0.13Actual $-0.11Actual $-0.06Actual $-0.26Actual $-0.17Actual $-0.17Actual $-0.34Actual $-0.42Actual $-0.38Actual $-6.65 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-239M$-172M$-106M$-40M$27M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-6.65 — — — — financials
Wed May 13, 2026Mar/2026 $-0.38 — — -123.5% -3.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.42 — — — — financials
Tue Aug 5, 2025Jun/2025 $-0.34 — — — — earnings
Thu May 8, 2025Mar/2025 $-0.17 — — — +22.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.17 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.26 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.06 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.11 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.13 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.04 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$25M$2M—$388,209$408,527$580,000—$647,867
Cost of revenue————————
Gross profit————————
Operating income$-149M$-126M—$-10M$-2M$-1M—$-1M
Net income$-133M$-239M—$-86M$-2M$-1M—$-1M
EPS (diluted)$-6.65$-0.38—$-0.42$-14.20$-0.17—$-0.17

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$19M$35M$21M$24M$6M$1M$2M$4M
Inventory————$1,078$1,595$4,300$2,750
Total current assets$27M$63M$224M$27M$6M$1M$3M$4M
Total assets$423M$621M$731M$692M$10M$3M$4M$4M
Long-term debt—————$64,370—$205,632
Total liabilities$186M$254M$216M$215M$923,394$1M$1M$840,107
Total equity$236M$367M$514M$478M$9M$2M$3M$3M

Implied volatility — last 90 days

113%210%308%405%503% Jun 07 — IV 163% · EM ±22.6%Jun 08 — IV 226% · EM ±29.8%Jun 09 — IV 176% · EM ±22.1%Jun 10 — IV 207% · EM ±24.5%Jun 11 — IV 197% · EM ±21.8%Jun 12 — IV 181% · EM ±18.5%Jun 15 — IV 367% · EM ±26.5%Jun 16 — IV 437% · EM ±25.8%Jun 17 — IV 452% · EM ±18.9%Jun 19 — IV 169% · EM ±37.4%Jun 22 — IV 191% · EM ±39.9%Jun 23 — IV 172% · EM ±35.2%Jun 24 — IV 174% · EM ±34.8%Jun 25 — IV 188% · EM ±36.8%Jun 26 — IV 184% · EM ±35.2%Jun 29 — IV 155% · EM ±27.4%Jun 30 — IV 173% · EM ±29.8%Jul 01 — IV 205% · EM ±34.2%Jul 02 — IV 175% · EM ±28.3%Jul 03 — IV 182% · EM ±28.5%Jul 06 — IV 170% · EM ±23.5%Jul 07 — IV 195% · EM ±25.7%Jul 08 — IV 181% · EM ±22.7%Jul 09 — IV 194% · EM ±23.0%Jul 10 — IV 179% · EM ±19.8%Jul 13 — IV 503% · EM ±42.0%Jul 14 — IV 258% · EM ±18.6%Jul 15 — IV 271% · EM ±16.0%Jul 20 — IV 187% · EM ±44.3%Jul 21 — IV 181% · EM ±42.2%Jul 22 — IV 186% · EM ±42.6%Jul 23 — IV 179% · EM ±40.2%Jul 24 — IV 189% · EM ±41.7%Jul 27 — IV 171% · EM ±35.7%Jul 28 — IV 163% · EM ±33.4%Jul 29 — IV 172% · EM ±34.5%Jul 30 — IV 226% · EM ±44.4%Jul 31 — IV 170% · EM ±32.6%Aug 03 — IV 169% · EM ±29.9%Aug 04 — IV 175% · EM ±30.1%Aug 05 — IV 179% · EM ±29.9%Aug 06 — IV 181% · EM ±29.4%Aug 07 — IV 147% · EM ±22.9%Aug 10 — IV 187% · EM ±26.0%Aug 11 — IV 159% · EM ±20.9%Aug 12 — IV 148% · EM ±18.5%Aug 13 — IV 147% · EM ±17.4%Aug 14 — IV 165% · EM ±18.3%Aug 17 — IV 168% · EM ±14.0%Aug 18 — IV 200% · EM ±14.5%Aug 19 — IV 199% · EM ±11.7%Aug 20 — IV 311% · EM ±13.0%Aug 24 — IV 154% · EM ±32.1%Aug 25 — IV 157% · EM ±32.1%Aug 26 — IV 148% · EM ±29.7%Aug 27 — IV 130% · EM ±25.6%Aug 28 — IV 133% · EM ±25.5%Aug 31 — IV 121% · EM ±21.4%Sep 01 — IV 113% · EM ±19.5%Sep 02 — IV 152% · EM ±25.4%Sep 03 — IV 123% · EM ±19.9%Sep 04 — IV 118% · EM ±18.4%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in